This article is more than 5 years old. Information may no longer be current.

Teva UK launches generic glaucoma drop

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CASTLEFORD, England — Teva Pharmaceutical subsidiary Teva UK has launched a generic version of Cosopt, Teva Pharmaceutical announced in a press release.

Cosopt (dorzolamide/timolol 20 mg/5 mg/mL ophthalmic solution, Merck) is indicated for treating elevated IOP among patients with open-angle glaucoma or pseudoexfoliative glaucoma who do not respond to topical beta-blocker monotherapy, the release said.

"We are pleased to add this product to our ever-expanding product portfolio — the widest of any U.K. generics supplier," Kim Innes, commercial director for Teva UK, said in the release.

Teva UK's generic version of the drug is now available.